Endpoint Research is a private CRO established in 1990, offering Phase I/II-IV clinical development services in Canada, the US, and Europe. Endpoint has successfully managed over 225 clinical trials during this period of time and has developed an international structure over the past eight years by establishing offices in the US and the UK, and most recently in Central and Western Europe through strategic partnerships.

Endpoint’s services include: project management, clinical and medical monitoring, strategic consultation, and data management (ORACLE Clinical ™). Endpoint’s experience encompasses all therapeutic areas. Endpoint has extensive experience in the conduct of complex trials (e.g. oncology, neurodegenerative diseases, respiratory, immunology, infectious diseases and transplantation). Endpoint also offers specialized services to the biotechnology industry.

Endpoint provides a full range of contract services and resources to ensure expedited clinical development and successful submission to the FDA and other regulatory bodies. Endpoint offers single service offerings such as monitoring to fully integrated services in the management of product development programs. Endpoint has successfully serviced the pharmaceutical, biotechnology and medical device industries for 15 years.

• Phase I/II-IV clinical trials implementation, conduct, management and monitoring
• Conduct of regional and multinational trials in the United States, Canada and Europe.
• Centralized data management using ORACLE Clinical™
• Strategic medical consultation for drug development design and planning
• Medical Monitoring.

In working extensively in the following complex therapeutic areas, Endpoint has been involved with compounds ranging from vaccines to biological response modifiers:

• Oncology
• Neurodegenerative diseases
• Respiratory
• Immunology
• Infectious diseases
• Transplantation

North America

Headquarters Office
2595 Skymark Avenue, Suite 210
Mississauga, Ontario L4W 4L5
Canada

USA

U.S.A. Office
24 New England Executive Park
Suite# 245
Burlington, MA 01803
USA

Europe

U.K. Office
Logan Building
Roslin Biocentre
Roslin
Midlothian, Scotland
EH25 9TT

Canada

Renée Blanchette
VP Business Development
T: 416 626 0299
F: 416 626 2063

USA

Scott Nivens
Director Business Development
T: 713 807 7044
F: 713 807 7054

Europe

Gillian Shields
Manager Business Development
T: + 44 (0) 1698 464 160
F: + 44 (0) 1698 464 161

Contact Information

Endpoint Research
Renée Blanchette, VP of Business Development
2595 Skymark Ave, Suite 210
Mississauga, Ontario L4W 4L5 Canada
Phone: 416-626-0299
Fax: 416-626-2063
E-mail:

If you are interested in contacting this provider to receive further information about the services they offer, please fill out the form below to send a direct e-mail message.

Name:
Address:
City:
State:
Zip:
Phone:
Email address:
Message:
	Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.